Evidence map›Paper›PMID 41578942›Full record

ArticleRheumatology (Oxford, England)2026

Development of a tool to map SSc pain sources, characteristics and management experiences: the SPIN Pain Assessment Tool.

Tiffany Dal Santo, Marie-Eve Carrier, Elsa-Lynn Nassar, Cassidy Dal Santo, Sophie Hu, Linda Kwakkenbos, Susan J Bartlett, Rina S Fox, Yvonne C Lee, John Varga and 2 more

Abstract read
In one paragraph

Article in Rheumatology (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Tiffany Dal SantoLady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada.
Marie-Eve CarrierLady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada.
Elsa-Lynn NassarLady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada.
Cassidy Dal SantoLady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada.
Sophie HuLady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada.
Linda KwakkenbosDepartment of Clinical Psychology, Behavioural Science Institute, Radboud University, Nijmegen, The Netherlands.
Susan J BartlettDepartment of Medicine, McGill University, Montreal, QC, Canada.ORCID 0000-0001-9755-2490
Rina S FoxDepartment of Psychology, University of Arizona, Tucson, AZ, USA.
Yvonne C LeeDepartment of Medicine (Rheumatology) and Preventive Medicine, Northwestern University, Chicago, IL, USA.
John VargaDivision of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.
Brett D ThombsLady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada.ORCID 0000-0002-5644-8432
Scleroderma Patient-centered Intervention Network Pain Patient Advisory Team

Funding

Mentored Patient-Oriented Research of Novel Mechanisms Linking Pain, Sleep-Wake Patterns, and Autonomic Activity in Rheumatic DiseasesK24AR080840 · NIAMS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Yvonne Claire Lee · 2023 to 2026
$764k
Arthritis Society Canada Ignite Innovation Grant 22-0000000130Canada Research ChairCanadian Institutes of Health Research (CIHR)Fonds de Recherche du Québec-Santé (FRQS) Master's Training ScholarshipJewish General Hospital Foundation, Montréal, Québec, CanadaLady Davis Institute for Medical Research of the Jewish General HospitalMcGill UniversityMontréal, QuébecNIAMS NIH HHS K24 AR080840NIH HHS K24AR080840Scleroderma Association of BCScleroderma AtlanticScleroderma AustraliaScleroderma CanadaScleroderma ManitobaScleroderma New South Wales and Scleroderma Victoria and the Scleroderma Foundation of CaliforniaScleroderma SASKScleroderma Society of OntarioSclérodermie Québec
6 · The paper itself

Abstract

objectivePeople with SSc report pain from multiple sources. Objectives were to develop a tool to map sources of pain in SSc, determine characteristics of pain from different sources and understand pain management experiences.

methodsWe referred to existing research and clinical pain assessment tools and partnered with a 4-member Patient Advisory Team to develop an initial tool version. The tool included questions on SSc pain sources and, for each source, questions on pain source intensity and interference, temporality and predictability, sensory experience and attempted pain management techniques. To further refine the tool, we conducted nominal group technique (NGT) sessions with people living with SSc and received feedback from healthcare providers who care for people with SSc. Finally, we conducted individual usability testing sessions with people living with SSc.

resultsWe conducted six NGT sessions (five English, one French; 22 total participants). We received feedback from 18 healthcare providers, and conducted five individual usability testing sessions. The final version of our Scleroderma Patient-centered Intervention Network (SPIN) pain assessment tool included 18 items on pain sources (plus an 'other' category), and for each pain source, 12 questions on pain intensity and interference, temporality and predictability, sensory experience and management.

conclusionThe SPIN pain assessment tool includes critical information on pain sources important to people with SSc. It provides a useful tool to study the epidemiology of the complex pain experience in SSc, including pain sources and how pain is experienced.

Indexed as

PainPain ManagementPain MeasurementScleroderma, SystemicAdultAgedFemaleHumansMaleMiddle Agednominal group techniquepainqualitative methodsSSctool development

Identifiers

PMID41578942
PMCPMC13396839

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.